Latest updates for Series C

Fresh curated links around Series C are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Corgi, which uses AI to provide insurance for startups, raised a $106M Series B1 at a $2.6B valuation, up from $1.3B on
  • CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine
  • Insurance startup Corgi hits $1.3B valuation 4 months after its Series A

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

techmeme.com /2 days ago

Corgi, which uses AI to provide insurance for startups, raised a $106M Series B1 at a $2.6B valuation, up from $1.3B on...

Dominic-Madori Davis / TechCrunch: Corgi, which uses AI to provide insurance for startups, raised a $106M Series B1 at a $2.6B valuation, up from $1.3B on May 6, for a total fundin...

Read source
biopharmadive.com /3 weeks ago

CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine

A Series D round led by Venrock will support an ongoing Phase 2 study, and planned Phase 3 trial, of an oral drug the biotech sees as a differentiated option for patients with pers...

Read source
techcrunch.com /3 weeks ago

Insurance startup Corgi hits $1.3B valuation 4 months after its Series A

Corgi announced on Wednesday a $160 million Series B, led by TCV, valuing the startup at $1.3 billion.

Read source
pehub.com /1 month ago

Cerberus Capital completes single-asset CV for Subsea Communications

The continuation vehicle secured approximately $2.3 billion in commitments and was led by CVC Secondary Partners. The post Cerberus Capital completes single-asset CV for Subsea Com...

Read source
fiercebiotech.com /2 weeks ago

Create Medicines fashions $122M fundraise for in vivo CAR-T dreams

As the wave of in vivo CAR-T hype crests, Create Medicines is catching the swell with a $122 million series B meant to back its early pipeline of autoimmune and cancer candidates.

Read source
fiercebiotech.com /1 month ago

E2 lands $80M series C for next-gen thrombectomy treatment

California-based medtech E2 has raised $80 million in a series C funding round as it looks to commercialize its pulmonary embolism treatment.

Read source
thenextweb.com /3 weeks ago

Corgi reaches a $1.3bn valuation four months after its Series A, with TCV leading a $160m round

The Y Combinator-backed AI-native insurance carrier closed its Series A in January at a $630m valuation. The Series B doubles that figure and funds expansion beyond startup insuran...

Read source
thebridge.jp /2 weeks ago

FUNDiT Conducts Series D Round for IT Business Roll-Up

FUNDiT, which specializes in M&A roll-ups of small to medium-sized IT businesses, announced on the 11th that it has conducted a third-party allocation of shares in its Series D...

Read source
finextra.com /2 weeks ago

Embat secures €30 million Series B

Treasury management fintech Embat has raised €30 million from AI-focused investement fund Cathay Innovation with support from existing investors.

Read source
techcrunch.com /1 month ago

Sources: Cursor in talks to raise $2B+ at $50B valuation as enterprise growth surges

Returning backers a16z and Thrive are expected to lead the round.

Read source
vmblog.com /1 month ago

Coder Secures $90M Series C Led by KKR to Advance Secure Enterprise AI Development

Coder announced a $90 million Series C led by funds managed by KKR, with participation from Qube Research & Technologies (QRT),

Read source
fiercebiotech.com /1 month ago

Terremoto takes $108M series C to fuel clinical trials of AKT1 inhibitors

Terremoto Biosciences has spelt out how the California biotech will use a $108 million series C round to continue its efforts to broaden the covalent drug alphabet.

Read source
medcitynews.com /1 month ago

With $100M Raise, Chapter Targets Medicare Mismatches for Seniors

Chapter’s Series E round was led by Generation Investment Management, with participation from Fifth Down Capital, 8VC, Stripes, XYZ Venture Capital, Addition, Narya Capital, Susa V...

Read source
ffnews.com /3 weeks ago

Corgi Raises $160M Series B at $1.3B Valuation

Corgi announced it has raised $160 million in Series B funding at a $1.3 billion valuation, advancing its mission to build the first AI-native, full-stack insurance platform for st...

Read source
alternativecreditinvestor.com /1 month ago

Founders First Capital Partners closes second Change Catalyst Fund at $12m

Founders First Capital Partners (FFCP) has announced the oversubscribed first close of its Change Catalyst Fund II (CCF II) at $12m (£8.9m). The new fund will invest in growing ser...

Read source
thebridge.jp /1 month ago

Residential Solar Power PPA “Share Denki” Operator Raises Additional ¥862 Million in Series C

On the 17th, Sharing Energy, the operator of the residential solar power PPA service “Share Denki,” announced that it has raised a total of ¥862 million through a third-party allot...

Read source
alternativecreditinvestor.com /1 month ago

CVC Credit closes fourth CLO equity fund at $1bn

CVC Credit has raised $1bn (£740.4m) of commitments for its fourth collateralised loan obligation (CLO) equity fund at final close, ahead of target and above its previous fund. Acr...

Read source
fiercebiotech.com /3 weeks ago

CellCentric raises $220M series D to advance myeloma drug through registration, eyes potential IPO

In the last three years, CellCentric CEO Will West has been on a journey that has transformed how he thinks about the future of his company. He used to be “obsessed with pharma dea...

Read source
techcrunch.com /3 days ago

Triomics nabs $22M to bring oncology-specific AI to cancer centers

The Series B round was led by Battery Ventures.

Read source
seekingalpha.com /2 weeks ago

CEL-SCI prices $7.2M offering at $1.20 per share

Read source
thequantuminsider.com /1 month ago

Quantum Art Extends Series A Funding to $140 Million with Participation from Global Financial Leaders

Insider Brief PRESS RELEASE —  Quantum Art, a developer of full-stack trapped-ion quantum computers, today announced that it has extended its recently announced Series A financing...

Read source
pharmexec.com /1 week ago

<![CDATA[Pharma Funding Roundup: Violet Therapeutics' $4.75 Million Seed Extension Financing, Full-Life Technologies...

Read source
yourstory.com /1 month ago

Capital-A raises Rs 160 Cr in first close of Fund II

The fund, which focuses on manufacturing startups, is targeting a total base corpus of Rs 300 crore, with a greenshoe option to selectively upsize to Rs 400 crore.

Read source
quantumcomputingreport.com /3 weeks ago

Quantum Motion Secures $160M Series C to Scale Silicon Spin QPUs

Quantum Motion, a developer of silicon transistor-based quantum computers, has successfully closed a $160 million Series C funding round. The investment was co-led by DCVC and Kemb...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Series C

blogs.vmware.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

ffnews.com

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source

quantumcomputingreport.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source